Prostate Acinar Adenocarcinoma
Gleason Grading
Circumscribed nodule of closely packed but
separate, uniform, rounded to oval, medium-
1
sized acini
Should not be diagnosed regardless of the type
of specimen, with extremely rare exceptions
Fairly circumscribed, yet at the edge of the
tumor nodule there may be minimal infiltration
2 Glands are more loosely arranged and not quite
as uniform as Gleason pattern 1
Very rarely diagnosed
Well-formed glands (with lumina)
3
Separate, Non-fused
Infiltration
Ill-defined, poorly formed glands
Gland fusion
4
ALL cribriform glands
Hypernephromatoid
Glomerulations (possibly)
Ductal Adenocarcinoma
Often Disqualifies from Active Surveillance
Essentially no glandular differentiation:
• solid sheets
5 • cords
• single cells
Comedocarcinoma with central necrosis
Biopsies:
Gleason Scoring
Most common + Second most common = Score
• No tertiary pattern assigned
• In the setting of high-grade cancer one should ignore lower-grade patterns if they occupy less
than 5% of the area of the tumor. (e.g., 98% pattern 4 and 2% pattern 3 → 4+4=8)
• High-grade tumor of any quantity, as long as it was identified at low to medium magnification
should be included. (e.g., 98% pattern 3 and 2% pattern 4 → 3+4=7)
• On needle biopsies with patterns 3, 4, and 5, both the primary pattern and the highest grade
should be recorded. Consequently, tumors with Gleason score 3 + 4 and a tertiary pattern 5
would be recorded as Gleason score 3 + 5 = 8.
Prostatectomies:
Most common + Second most common = Score, with tertiary pattern if present
• In the setting of high-grade cancer one should ignore lower-grade patterns if they occupy less
than 5% of the area of the tumor.
Grade Groups
Grade Group Gleason Score
1 ≤6
2 3+4=7
3 4+3=7
4 8
5 9-10
Active Surveillance
NCCN Inclusion Criteria:
Absolute (Low risk):
• Gleason Score ≤6
• PSA <10 ng/mL
• Clinical stage <T2a (Tumor involves one-half of one lobe or less)
Especially if (Very low risk):
• Fewer than 3 prostate biopsy cores positive, all ≤50%
• PSA density <0.15 ng/mL/g
NCCN Progression Criteria: (initiates transition to curative therapy)
• Gleason grade 4 or 5 on repeat biopsy
• Prostate cancer found in a greater number of biopsies or greater extent of biopsies